Discover the full directors' dealings record of INTERCEPT PHARMACEUTICALS INC, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was disclosed on 12 February 2016 (Attribution). Among the most active insiders: Duncan Barbara Gayle. The full history is accessible without an account.
18
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
10 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.